Crossmark

Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?

Crossref DOI link: https://doi.org/10.1016/j.nefro.2023.01.002

Published Print: 2024-03

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ozer, Hakan http://orcid.org/0000-0001-9174-0351
Baloglu, Ismail http://orcid.org/0000-0002-8751-5490
Topkac, Ali http://orcid.org/0000-0003-0608-1641
Ozturk, Yasin http://orcid.org/0000-0003-2634-2677
Yonet, Fethi http://orcid.org/0000-0002-8534-3170
Daglı, Furkan http://orcid.org/0000-0003-1775-8937
Kilinc, İbrahim http://orcid.org/0000-0002-7729-7557
Turkmen, Kultigin http://orcid.org/0000-0002-1667-7716
License Information

Text and Data Mining valid from 2024-03-01

Text and Data Mining valid from 2024-03-01

Version of Record valid from 2023-01-11
More Information

This article is maintained by: Elsevier

Article Title: Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?

Journal Title: Nefrología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.nefro.2023.01.002

Content Type: article

Copyright: © 2023 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.